The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.

PubWeight™: 3.71‹?› | Rank: Top 1%

🔗 View Article (PMID 7887548)

Published in Ann Intern Med on April 15, 1995

Articles citing this

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care (1999) 8.33

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA (2003) 7.91

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA (2002) 6.61

Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ (2007) 3.36

Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20

Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem (2005) 3.15

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64

Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57

Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes (2014) 1.81

Neuropathic pain: a practical guide for the clinician. CMAJ (2006) 1.79

A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes (2009) 1.65

Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A (2004) 1.65

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med (2012) 1.50

Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes (2013) 1.31

Insulin resistance in the nervous system. Trends Endocrinol Metab (2012) 1.18

Diabetic neuropathy. Postgrad Med J (2006) 1.16

The factors associated with contact burns from therapeutic modalities. Ann Rehabil Med (2012) 1.14

Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes (2015) 1.08

The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort. Diabetes Care (2013) 1.07

Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care (2010) 1.05

Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Investig (2011) 1.03

Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure. J Diabetes Investig (2012) 1.03

Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud (2009) 1.00

Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. Transl Res (2012) 0.97

Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies. Am J Pathol (2010) 0.97

Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes. Diabetes Care (2013) 0.96

The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care (2007) 0.95

The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol (2009) 0.94

Advanced Diabetic Neuropathy: A Point of no Return? Rev Diabet Stud (2006) 0.94

Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care (2010) 0.93

Carpal tunnel syndrome and peripheral polyneuropathy in patients with end stage kidney disease. J Korean Med Sci (2011) 0.93

The spectrum of diabetic neuropathies. Phys Med Rehabil Clin N Am (2008) 0.92

Racial disparities in diabetes-related preventive care: results from the Missouri Behavioral Risk Factor Surveillance System. Prev Chronic Dis (2006) 0.91

Maximising engagement, motivation and long term change in a Structured Intensive Education Programme in Diabetes for children, young people and their families: Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE). BMC Pediatr (2009) 0.89

Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes. Exp Diabetes Res (2008) 0.89

Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. Ther Clin Risk Manag (2011) 0.87

Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Prefer Adherence (2011) 0.87

Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy. Diabetes Metab Res Rev (2014) 0.86

Treatment of diabetic sensory polyneuropathy. Curr Treat Options Neurol (2011) 0.86

Cross-sectional survey of diabetic neuropathy in Kanagawa and clinical significance of a touch test using tissue paper. J Diabetes Investig (2012) 0.86

Update on the management of diabetic polyneuropathies. Diabetes Metab Syndr Obes (2011) 0.85

Pressure pain precedes development of type 2 disease in Zucker rat model of diabetes. Neurosci Lett (2008) 0.84

Pharmacological evaluation of rat dorsal root ganglion neurons as an in vitro model for diabetic neuropathy. J Pain Res (2011) 0.84

Painful diabetic neuropathy: an update. Ann Neurosci (2011) 0.83

Screening for diabetic cardiac autonomic neuropathy using a new handheld device. J Diabetes Sci Technol (2012) 0.83

Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care (2008) 0.83

Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats. Am J Physiol Endocrinol Metab (2013) 0.83

Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes: retrospective analysis of the DCCT study. BMC Endocr Disord (2013) 0.82

A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy. Korean J Ophthalmol (2009) 0.82

Prevalence and related risk-factors of peripheral neuropathy in children with insulin-dependent diabetes mellitus. J Res Med Sci (2013) 0.81

Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81

Relationship of urologic complications with health-related quality of life and perceived value of health in men and women with type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) cohort. Diabetes Care (2015) 0.80

Description of the Sphingolipid Content and Subspecies in the Diabetic Cornea. Curr Eye Res (2014) 0.80

Prevalence and correlates of diabetic peripheral neuropathy in a Saudi Arabic population: a cross-sectional study. PLoS One (2014) 0.80

Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists. Endocrinology (2013) 0.78

An association analysis of lipid profile and diabetic cardiovascular autonomic neuropathy in a Chinese sample. Lipids Health Dis (2016) 0.78

Peripheral insensate neuropathy-is height a risk factor? J Clin Diagn Res (2012) 0.77

Management of diabetic neuropathy. Malays J Med Sci (2003) 0.77

Follow-up of advanced diabetic neuropathy: useful variables and possible pitfalls. J Neurol (2005) 0.77

Neurogenic erectile dysfunction. Clin Auton Res (2001) 0.77

Multifocal Visual Evoked Potentials (mfVEP) in Diabetic Patients with and without Polyneuropathy. Open Ophthalmol J (2012) 0.77

Heme oxygenase-1 inhibits neuropathic pain in rats with diabetic mellitus. Neural Regen Res (2012) 0.77

Effectiveness of a structured educational intervention using psychological delivery methods in children and adolescents with poorly controlled type 1 diabetes: a cluster-randomized controlled trial of the CASCADE intervention. BMJ Open Diabetes Res Care (2016) 0.76

Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy. PLoS One (2014) 0.76

Clinical Findings of Asymptomatic Carpal Tunnel Syndrome in Patients With Diabetes Mellitus. Ann Rehabil Med (2016) 0.75

Comparison of Dry Eye Parameters between Diabetics and Non-Diabetics in District of Kuantan, Pahang. Malays J Med Sci (2016) 0.75

Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy. Front Endocrinol (Lausanne) (2017) 0.75

Relationship of Vascular Factors on Electrophysiologic Severity of Diabetic Neuropathy. Ann Rehabil Med (2016) 0.75

Improved A1C and Lipid Profile in Patients Referred to Diabetes Education Programs in a Wide Health Care Network: A Retrospective Study. Diabetes Spectr (2014) 0.75

Evaluation of Effect of Nishamalaki on STZ and HFHF Diet Induced Diabetic Neuropathy in Wistar Rats. J Clin Diagn Res (2016) 0.75

A Role for Insulin in Diabetic Neuropathy. Front Neurosci (2016) 0.75

Carpal tunnel release surgery and venous hypertension in early hemodialysis patients without amyloid deposits. ScientificWorldJournal (2013) 0.75

Altered Erythrocyte Glycolytic Enzyme Activities in Type-II Diabetes. Indian J Clin Biochem (2015) 0.75

Comparison of Gait Speed and Peripheral Nerve Function Between Chronic Kidney Disease Patients With and Without Diabetes. Ann Rehabil Med (2017) 0.75

Effect of cartilage oligomeric matrix protein angiopoietin-1 on peripheral nerves in db/db diabetic mice. Curr Ther Res Clin Exp (2008) 0.75